Clown Doctors and a Sedative Premedicant for Children Undergoing Surgery
NCT00886314 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2009-10-20
Summary
The purpose of the present investigation will be to determine whether a combination of clown doctor and parental presence is more effective than a combination of sedative premedication and parental presence for reducing anxiety in children and their parents and for improving parental satisfaction.
Conditions
Interventions
- DRUG
-
midazolam
Children in this group will be premedicated with oral midazolam syrup (0.3 mg.kg) at least 15 minutes before the surgical procedure and one of the parents will be present throughout the anesthesia induction process.
- OTHER
-
clown doctor
Children will interact with clowns before entering the operating room and will stay with them and one of the parents throughout the anesthesia induction process.
Sponsors & Collaborators
-
Shaare Zedek Medical Center
lead OTHER
Principal Investigators
-
Yaacov Gozal, MD · Shaare Zedek Medical Center, Jerusalem, Israel
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 2 Years
- Max Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-06-30
- Primary Completion
- 2009-09-30
Countries
- Israel
Study Locations
More Related Trials
-
Exposure-Based CBT for Youth With Blood and Injection Phobia and Chronic Illness
NCT07125287 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Facing Fears In-session or Out-session?
NCT03688360 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Nitrous Oxide in OCD: Pilot Study
NCT03826693 ·Status: RECRUITING ·Phase: PHASE2
-
Intervention Social Anxiety: Combining Parent-child Treatment
NCT06352463 ·Status: RECRUITING ·Phase: NA
-
Treatment of Pediatric Anxiety Disorders by Predicting Treatment Response Through Biocellular Markers and Sleep
NCT02189213 ·Status: TERMINATED ·Phase: NA
-
The Relative Effects of Three Parent-Intervention Components to Reduce Children's Anxiety
NCT05854602 ·Status: COMPLETED ·Phase: NA
-
Cerebellar Neuromodulation to Enhance Fear Extinction and Predict Response to Exposure Therapy
NCT03275337 ·Status: COMPLETED ·Phase: NA
-
Brief, Remote Treatment of Youth Injection Phobia and Measurement of Novel, Disorder-congruent Cognitive Bias Tasks
NCT04972006 ·Status: UNKNOWN ·Phase: NA
-
Imagery Rescripting and Imaginal Exposure for Social Anxiety: Mechanisms and Outcomes in an Analog Sample
NCT04635904 ·Status: UNKNOWN ·Phase: NA
-
2/2 D-Cycloserine Augmentation of CBT for Pediatric OCD
NCT01404208 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Adverse Events of Bilateral Single-shot VC/VS Gamma Capsulotomy for OCD: a Pilot Study
NCT02433886 ·Status: UNKNOWN ·Phase: PHASE2
-
D-Cycloserine Augmentation of Therapy for Pediatric Obsessive-Compulsive Disorder
NCT00864123 ·Status: COMPLETED ·Phase: PHASE2
-
Intravenous Ketamine in the Treatment of Obsessive-Compulsive Disorder
NCT01371110 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Efficacy of Targeted Memory Reactivation for Enhancing Exposure Therapy
NCT04663672 ·Status: COMPLETED ·Phase: NA
-
Overlapping Neural Circuits in Pediatric OCD
NCT02421315 ·Status: COMPLETED ·Phase: NA
-
Oxytocin Administration to Therapists and Its Effects on Patient-perceived Attunement and Responsiveness
NCT06332066 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Ultrashort Cognitive Behavioral Intervention for Tokophobia- A Prospective Randomized Single Blinded Controlled Trial
NCT02972112 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Naltrexone Treatment as Augmentation to SSRI in OCD Patients
NCT00234689 ·Status: COMPLETED ·Phase: NA
-
Inter-Brain Synchrony in Psychotherapy for Test Anxiety
NCT05336734 ·Status: COMPLETED ·Phase: NA
-
Treatment of Obsessive-Compulsive Disorder
NCT00000373 ·Status: COMPLETED ·Phase: PHASE4
-
Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project
NCT00742664 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Short Term Group Therapy for Anxiety Disorder
NCT00229281 ·Status: COMPLETED ·Phase: NA
-
Attention Bias Modification Treatment (ABMT) for Anxiety Disorders in Youth
NCT02460536 ·Status: COMPLETED ·Phase: NA
-
Treatment of Obsessive Compulsive Disorder in Children
NCT00074815 ·Status: COMPLETED ·Phase: PHASE3
-
Examining the Usage of Dopamine Blockers in OCD Patients
NCT00496925 ·Status: COMPLETED